Evidence map›Paper›PMID 31899295›Full record

ArticleBiochimica et biophysica acta. Molecular basis of disease2020

Mitochondrial genetics cooperate with nuclear genetics to selectively alter immune cell development/trafficking.

T C Beadnell, C Fain, C J Vivian, J C G King, R Hastings, M A Markiewicz, D R Welch

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Molecular basis of disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. CD4Scientific reports · 2024
    Article
  4. Article
  5. Neoantigens: promising targets for cancer therapy.Signal transduction and targeted therapy · 2023
    Review
  6. Article
  7. Review
  8. Mechanisms of breast cancer metastasis.Clinical & experimental metastasis · 2022
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

T C BeadnellDepartment of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America.
C FainDepartment of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America.
C J VivianDepartment of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America.
J C G KingDepartment of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America.
R HastingsDepartment of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America.
M A MarkiewiczDepartment of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America.
D R WelchDepartment of Cancer Biology, Department of Microbiology, Immunology and Genetics, The University of Kansas Cancer Center, The University of Kansas Medical Center, United States of America. Electronic address: dwelch@kumc.edu.
The University of Kansas Cancer Center · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
Novel Approaches for the Control of Microbial PathogensP30GM103326 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI YANKEE, THOMAS M. · 2012 to 2016
$5.3M
NCI NIH HHS P30 CA168524NIGMS NIH HHS P20 GM103418NIGMS NIH HHS P30 GM103326
6 · The paper itself

Abstract

The nuclear genome drives differences in immune cell populations and differentiation potentials, in part regulated by changes in metabolism. Despite this connection, the role of mitochondrial DNA (mtDNA) polymorphisms (SNP) in this process has not been examined. Using mitochondrial nuclear exchange (MNX) mice, we and others have shown that mtDNA strongly influences varying aspects of cell biology and disease. Based upon an established connection between mitochondria and immune cell polarization, we hypothesized that mtDNA SNP alter immune cell development, trafficking, and/or differentiation. Innate and adaptive immune cell populations were isolated and characterizated from the peritoneum and spleen. While most differences between mouse strains are regulated by nuclear DNA (nDNA), there are selective changes that are mediated by mtDNA differences (e.g., macrophage (CD11c) differentiation), These findings highlight how nuclear-mitochondrial crosstalk may alter pathology and physiology via regulation of specific components of the immune system.

Indexed as

Adaptive ImmunityAnimalsCD11 AntigensCell DifferentiationCell NucleusDNA, MitochondrialFemaleGenome, MitochondrialImmunity, InnateLymphocytesMacrophages, PeritonealMaleMiceModels, AnimalPolymorphism, Single NucleotideQuantitative Trait LociCD11 AntigensDNA, MitochondrialItgax protein, mouseDifferentiationImmuneMacrophageMitochondriaPolymorphismT cell

Identifiers

PMID31899295
PMCPMC7071984
OpenAlexW2998651897

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.